Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pere Santamaria

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Immunity|April 24, 2010
The long and winding road to understanding and conquering type 1 diabetesPere Santamaria
Reviews in Endocrine & Metabolic Disorders|September 23, 2003
Effector lymphocytes in islet cell autoimmunityPere Santamaria
Novartis Foundation Symposium|February 13, 2009
Genetic and therapeutic control of diabetogenic CD8+ T cellsPere Santamaria
Advances in Experimental Medicine and Biology|March 5, 2003
Cytokines and chemokines in autoimmune disease: an overviewPere Santamaria
Annals of the New York Academy of Sciences|December 18, 2003
Kinetic evolution of a diabetogenic CD8+ T cell responsePere Santamaria
Current Opinion in Immunology|October 18, 2005
CD8+ T cells in autoimmunityUlrich Walter, Pere Santamaria
Frontiers in Immunology|August 2, 2021
Re-Programming Autoreactive T Cells Into T-Regulatory Type 1 Cells for the Treatment of AutoimmunityPatricia Solé, Pere Santamaria
European Journal of Immunology|February 11, 2018
Nanoparticle-based approaches to immune tolerance for the treatment of autoimmune diseasesPau Serra, Pere Santamaria
Clinical Immunology (Orlando, Fla.)|February 24, 2015
Nanoparticle-based autoimmune disease therapyPau Serra, Pere Santamaria
Current Opinion in Biotechnology|January 10, 2022
Antigen-specific nanomedicines for the treatment of autoimmune disease: target cell types, mechanisms and outcomesYang Yang, Pere Santamaria
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Immunity|April 24, 2010
The long and winding road to understanding and conquering type 1 diabetesPere Santamaria
Reviews in Endocrine & Metabolic Disorders|September 23, 2003
Effector lymphocytes in islet cell autoimmunityPere Santamaria
Novartis Foundation Symposium|February 13, 2009
Genetic and therapeutic control of diabetogenic CD8+ T cellsPere Santamaria
Advances in Experimental Medicine and Biology|March 5, 2003
Cytokines and chemokines in autoimmune disease: an overviewPere Santamaria
Annals of the New York Academy of Sciences|December 18, 2003
Kinetic evolution of a diabetogenic CD8+ T cell responsePere Santamaria
Current Opinion in Immunology|October 18, 2005
CD8+ T cells in autoimmunityUlrich Walter, Pere Santamaria
Frontiers in Immunology|August 2, 2021
Re-Programming Autoreactive T Cells Into T-Regulatory Type 1 Cells for the Treatment of AutoimmunityPatricia Solé, Pere Santamaria
European Journal of Immunology|February 11, 2018
Nanoparticle-based approaches to immune tolerance for the treatment of autoimmune diseasesPau Serra, Pere Santamaria
Clinical Immunology (Orlando, Fla.)|February 24, 2015
Nanoparticle-based autoimmune disease therapyPau Serra, Pere Santamaria
Current Opinion in Biotechnology|January 10, 2022
Antigen-specific nanomedicines for the treatment of autoimmune disease: target cell types, mechanisms and outcomesYang Yang, Pere Santamaria
Pageof 16